167 related articles for article (PubMed ID: 8097925)
21. Clinical pharmacology of epanolol. Pharmacodynamic aspects.
Harry JD
Drugs; 1989; 38 Suppl 2():18-27. PubMed ID: 2575976
[TBL] [Abstract][Full Text] [Related]
22. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
Ruilope LM
Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
[TBL] [Abstract][Full Text] [Related]
23. Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.
Bonde J; Svendsen TL; Lyngborg K; Mehlsen J; Trap-Jensen J
Br J Clin Pharmacol; 1987 Jan; 23(1):35-40. PubMed ID: 2880603
[TBL] [Abstract][Full Text] [Related]
24. Epanolol. A new once-daily antianginal agent: dose finding and long term efficacy.
Akhras F; Jackson G
Drugs; 1989; 38 Suppl 2():28-34. PubMed ID: 2575977
[TBL] [Abstract][Full Text] [Related]
25. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
26. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
Lund-Johansen P; Omvik P; Nordrehaug JE; White W
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
[TBL] [Abstract][Full Text] [Related]
27. Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1).
Meekers J; Missotten A; Fagard R; Demuynck D; Harvengt C; Pas P; Billiet L; Amery A
Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):294-306. PubMed ID: 238480
[TBL] [Abstract][Full Text] [Related]
28. Acute haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.
Omvik P; Lund-Johansen P
Eur Heart J; 1991 Jun; 12(6):736-40. PubMed ID: 1860471
[TBL] [Abstract][Full Text] [Related]
29. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
[TBL] [Abstract][Full Text] [Related]
30. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Polónia J; Barbosa L; Silva JA; Bertoquini S
Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
[TBL] [Abstract][Full Text] [Related]
31. Effects of carvedilol on atrial natriuretic peptide, catecholamines, and hemodynamics in hypertension at rest and during exercise.
Omvik P; Lund-Johansen P; Myking O
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S90-6. PubMed ID: 1378157
[TBL] [Abstract][Full Text] [Related]
32. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.
Lund-Johansen P
Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971
[TBL] [Abstract][Full Text] [Related]
33. Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.
Dreslinski GR; Messerli FH; Dunn FG; Suarez DH; Reisin E; Frohlich ED
Circulation; 1982 Jun; 65(7):1365-8. PubMed ID: 6122514
[TBL] [Abstract][Full Text] [Related]
34. The effect of long-term beta-adrenergic receptor blockade on the oxygen delivery and extraction relationship in patients with coronary artery disease.
Eynon N; Sagiv M; Amir O; Ben-Sira D; Goldhammer E; Amir R
J Cardiopulm Rehabil Prev; 2008; 28(3):189-94. PubMed ID: 18496318
[TBL] [Abstract][Full Text] [Related]
35. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
Saner H; Seiler A; Mahler F
Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
[TBL] [Abstract][Full Text] [Related]
36. Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.
Salonen JT; Taskinen E; Salonen R; Seppänen K; Venäläinen J; Rauramaa R
Am J Cardiol; 1986 Nov; 58(12):35E-40E. PubMed ID: 2878600
[TBL] [Abstract][Full Text] [Related]
37. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.
Nodari S; Metra M; Dei Cas L
Eur J Heart Fail; 2003 Oct; 5(5):621-7. PubMed ID: 14607201
[TBL] [Abstract][Full Text] [Related]
38. Dose finding in angina--results with epanolol.
Omland TM; von Brandis C; Abrahamsen AM
Drugs; 1989; 38 Suppl 2():35-8. PubMed ID: 2575978
[No Abstract] [Full Text] [Related]
39. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
40. Effects of epanolol and metoprolol on the heart measured by 24-hour holter monitoring.
Withagen AJ; Corbeij HM; Huige MC; Kragten JA; Vermeulen A
Drugs; 1989; 38 Suppl 2():67-9. PubMed ID: 2575985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
